Northern Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93B | Sell |
13,820,379
-237,577
| -2% | -$33.3M | 0.25% | 70 |
|
|
2025
Q4 | $1.73B | Sell |
14,057,956
-258,700
| -2% | -$31.4M | 0.22% | 78 |
|
|
2025
Q3 | $1.59B | Sell |
14,316,656
-92,667
| -0.6% | -$10.5M | 0.2% | 92 |
|
|
2025
Q2 | $1.6B | Sell |
14,409,323
-27,059
| -0.2% | -$2.88M | 0.22% | 80 |
|
|
2025
Q1 | $1.62B | Sell |
14,436,382
-478,713
| -3% | -$49.4M | 0.24% | 76 |
|
|
2024
Q4 | $1.38B | Buy |
14,915,095
+2,458,954
| +20% | +$221M | 0.2% | 91 |
|
|
2024
Q3 | $1.04B | Sell |
12,456,141
-514,023
| -4% | -$39.2M | 0.17% | 110 |
|
|
2024
Q2 | $890M | Sell |
12,970,164
-259,104
| -2% | -$17.3M | 0.15% | 123 |
|
|
2024
Q1 | $969M | Sell |
13,229,268
-796,630
| -6% | -$61.3M | 0.17% | 119 |
|
|
2023
Q4 | $1.14B | Sell |
14,025,898
-896,590
| -6% | -$69.8M | 0.21% | 96 |
|
|
2023
Q3 | $1.12B | Buy |
14,922,488
+504,475
| +3% | +$38.8M | 0.22% | 85 |
|
|
2023
Q2 | $1.11B | Sell |
14,418,013
-131,813
| -0.9% | -$10.5M | 0.21% | 89 |
|
|
2023
Q1 | $1.21B | Sell |
14,549,826
-392,670
| -3% | -$32.5M | 0.24% | 80 |
|
|
2022
Q4 | $1.28B | Sell |
14,942,496
-359,122
| -2% | -$28.4M | 0.27% | 75 |
|
|
2022
Q3 | $944M | Sell |
15,301,618
-11,551
| -0.1% | -$728K | 0.22% | 89 |
|
|
2022
Q2 | $947M | Buy |
15,313,169
+343,918
| +2% | +$21.3M | 0.2% | 98 |
|
|
2022
Q1 | $890M | Buy |
14,969,251
+430,810
| +3% | +$27.5M | 0.16% | 122 |
|
|
2021
Q4 | $1.06B | Buy |
14,538,441
+60,475
| +0.4% | +$4.17M | 0.17% | 107 |
|
|
2021
Q3 | $1.01B | Sell |
14,477,966
-602,918
| -4% | -$42.4M | 0.18% | 106 |
|
|
2021
Q2 | $1.04B | Sell |
15,080,884
-48,262
| -0.3% | -$3.22M | 0.18% | 104 |
|
|
2021
Q1 | $978M | Sell |
15,129,146
-114,683
| -0.8% | -$7.39M | 0.18% | 107 |
|
|
2020
Q4 | $888M | Sell |
15,243,829
-609,237
| -4% | -$36.8M | 0.17% | 114 |
|
|
2020
Q3 | $1B | Sell |
15,853,066
-228,140
| -1% | -$15.8M | 0.22% | 85 |
|
|
2020
Q2 | $1.24B | Buy |
16,081,206
+526,283
| +3% | +$40.3M | 0.29% | 65 |
|
|
2020
Q1 | $1.16B | Buy |
15,554,923
+112,564
| +0.7% | +$7.78M | 0.33% | 60 |
|
|
2019
Q4 | $1B | Sell |
15,442,359
-1,687,348
| -10% | -$110M | 0.22% | 85 |
|
|
2019
Q3 | $1.09B | Sell |
17,129,707
-58,034
| -0.3% | -$3.79M | 0.26% | 76 |
|
|
2019
Q2 | $1.16B | Buy |
17,187,741
+347,443
| +2% | +$22.9M | 0.28% | 69 |
|
|
2019
Q1 | $1.09B | Sell |
16,840,298
-147,343
| -0.9% | -$9.79M | 0.27% | 71 |
|
|
2018
Q4 | $1.06B | Buy |
16,987,641
+380,928
| +2% | +$26.6M | 0.3% | 66 |
|
|
2018
Q3 | $1.28B | Sell |
16,606,713
-216,479
| -1% | -$16.3M | 0.31% | 60 |
|
|
2018
Q2 | $1.19B | Buy |
16,823,192
+325,246
| +2% | +$23M | 0.3% | 63 |
|
|
2018
Q1 | $1.24B | Sell |
16,497,946
-206,790
| -1% | -$16.4M | 0.32% | 59 |
|
|
2017
Q4 | $1.2B | Sell |
16,704,736
-333,007
| -2% | -$25.3M | 0.3% | 62 |
|
|
2017
Q3 | $1.38B | Buy |
17,037,743
+607,267
| +4% | +$46.4M | 0.36% | 50 |
|
|
2017
Q2 | $1.16B | Buy |
16,430,476
+116,780
| +0.7% | +$7.77M | 0.33% | 57 |
|
|
2017
Q1 | $1.11B | Sell |
16,313,696
-578,176
| -3% | -$40.7M | 0.32% | 55 |
|
|
2016
Q4 | $1.21B | Sell |
16,891,872
-504,596
| -3% | -$37.5M | 0.37% | 47 |
|
|
2016
Q3 | $1.38B | Sell |
17,396,468
-326,108
| -2% | -$26.5M | 0.43% | 44 |
|
|
2016
Q2 | $1.48B | Sell |
17,722,576
-563,405
| -3% | -$50M | 0.48% | 39 |
|
|
2016
Q1 | $1.69B | Sell |
18,285,981
-575,091
| -3% | -$51.9M | 0.56% | 31 |
|
|
2015
Q4 | $1.91B | Sell |
18,861,072
-1,420,945
| -7% | -$148M | 0.63% | 28 |
|
|
2015
Q3 | $1.99B | Sell |
20,282,017
-854,503
| -4% | -$94.9M | 0.66% | 22 |
|
|
2015
Q2 | $2.47B | Sell |
21,136,520
-153,403
| -0.7% | -$16.8M | 0.75% | 16 |
|
|
2015
Q1 | $2.09B | Buy |
21,289,923
+147,606
| +0.7% | +$15M | 0.63% | 23 |
|
|
2014
Q4 | $1.99B | Sell |
21,142,317
-262,185
| -1% | -$27.1M | 0.6% | 29 |
|
|
2014
Q3 | $2.28B | Sell |
21,404,502
-259,415
| -1% | -$25.4M | 0.72% | 21 |
|
|
2014
Q2 | $1.8B | Sell |
21,663,917
-178,799
| -0.8% | -$13.9M | 0.56% | 29 |
|
|
2014
Q1 | $1.55B | Buy |
21,842,716
+177,551
| +0.8% | +$13.9M | 0.49% | 37 |
|
|
2013
Q4 | $1.63B | Sell |
21,665,165
-134,231
| -0.6% | -$9.35M | 0.52% | 36 |
|
|
2013
Q3 | $1.37B | Sell |
21,799,396
-683,549
| -3% | -$40.9M | 0.48% | 36 |
|
|
2013
Q2 | $1.15B | Buy |
+22,482,945
| New | +$1.17B | 0.42% | 41 |
|
Other funds holding GILD
VCM
VPM
Northern Trust's GILD Position: Q1 2026 in Review
Northern Trust reduced its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, selling an estimated $33.3M and leaving 13,820,379 shares worth $1.93B. The position accounts for 0.25% of the portfolio, ranked #70.
Northern Trust first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.47B in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Northern Trust held 13,820,379 shares of Gilead Sciences worth $1.93B as of Q1 2026.
- Northern Trust sold 237,577 Gilead Sciences shares in Q1 2026, an estimated $33.3M.
- Gilead Sciences made up 0.25% of Northern Trust's portfolio in Q1 2026, its #70 holding.
- Northern Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Gilead Sciences position peaked at $2.47B in Q2 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.